Hypoglycemic Agents Concept

subject area of

• 2022 Canadian Cardiovascular Society Guideline for Use of GLP-1 Receptor Agonists and SGLT2 Inhibitors for Cardiorenal Risk Reduction in Adults  Journal Articles
• 3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial  Journal Articles
• A 24-Week, Randomized, Treat-to-Target Trial Comparing Initiation of Insulin Glargine Once-Daily With Insulin Detemir Twice-Daily in Patients With Type 2 Diabetes Inadequately Controlled on Oral Glucose-Lowering Drugs  Journal Articles
• A Genome-Wide Association Study Identifies a Novel Major Locus for Glycemic Control in Type 1 Diabetes, as Measured by Both A1C and Glucose  Journal Articles
• A Glycemic Threshold Above Which the Improvement of β-Cell Function and Glycemia in Response to Insulin Therapy Is Amplified in Early Type 2 Diabetes: The Reversal of Glucotoxicity.  Journal Articles
• A Multicenter Observational Study of Incretin-based Drugs and Heart Failure  Journal Articles
• A Nurse-coordinated Model of Care versus Usual Care for Stage 3/4 Chronic Kidney Disease in the Community  Journal Articles
• A Practical Guide to the Use of Glucose-Lowering Agents With Cardiovascular Benefit or Proven Safety  Journal Articles
• A Systematic Review and Meta-Analysis of Hypoglycemia and Cardiovascular Events  Journal Articles
• A comparison of the assessment and management of cardiometabolic risk in patients with and without type 2 diabetes mellitus in Canadian primary care  Journal Articles
• A multicentre, randomized, double-blind placebo-controlled trial evaluating rosiglitazone for the prevention of atherosclerosis progression after coronary artery bypass graft surgery in patients with type 2 diabetes. Design and rationale of the VeIn-Coronary aTherOsclerosis and Rosiglitazone after bypass surgerY (VICTORY) trial  Journal Articles
• A randomized trial of adding insulin glargine vs. avoidance of insulin in people with Type 2 diabetes on either no oral glucose‐lowering agents or submaximal doses of metformin and/or sulphonylureas. The Canadian INSIGHT (Implementing New Strategies with Insulin Glargine for Hyperglycaemia Treatment) Study  Journal Articles
• A survey: perioperative diabetes medications and glucose control—time to re-examine management?  Journal Articles
• ACCORDION MIND: results of the observational extension of the ACCORD MIND randomised trial  Journal Articles
• AMP-activated protein kinase (AMPK) β1β2 muscle null mice reveal an essential role for AMPK in maintaining mitochondrial content and glucose uptake during exercise  Journal Articles
• AMP-activated protein kinase activator AICAR acutely lowers blood pressure and relaxes isolated resistance arteries of hypertensive rats  Journal Articles
• AMPK phosphorylation of ACC2 is required for skeletal muscle fatty acid oxidation and insulin sensitivity in mice  Journal Articles
• Acarbose in the treatment of elderly patients with type 2 diabetes  Journal Articles
• Addendum to Policies, Guidelines and Consensus Statements: Pharmacologic Management of Type 2 Diabetes: 2015 Interim Update  Journal Articles
• Adherence to Guidelines for Inpatient Pharmacologic Management of Type 2 Diabetes in Adults and Glycemic Outcomes  Journal Articles
• Adherence to Prescribing Recommendations Made on a Provincial Formulary  Journal Articles
• Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial  Journal Articles
• Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes  Journal Articles
• An integrative, in situ approach to examining K⁺ flux in resting skeletal muscle  Journal Articles
• An integrative, in situ approach to examining K⁺ flux in resting skeletal muscle  Journal Articles
• Anabolic and anticatabolic agents used in burn care: What is known and what is yet to be learned  Journal Articles
• Analysis of Health Utility Data When Some Subjects Attain the Upper Bound of 1: Are Tobit and CLAD Models Appropriate?  Journal Articles
• Angiotensin-Converting Enzyme Inhibitor Use and Major Cardiovascular Outcomes in Type 2 Diabetes Mellitus Treated With the Dipeptidyl Peptidase 4 Inhibitor Alogliptin  Journal Articles
• Anoxia differentially modulates multiple K⁺ currents and depolarizes neonatal rat adrenal chromaffin cells  Journal Articles
• Antidiabetic drugs for preventing atrial fibrillation: A new revolution?  Journal Articles
• Antihyperglycemic Medications: A Claims-Based Estimate of First-line Therapy Use Prior to Initialization of Second-line Medications  Journal Articles
• Assessment of the cardioprotective effect of liraglutide on methotrexate induced cardiac dysfunction through suppression of inflammation and enhancement of angiogenesis in rats.  Journal Articles
• Assessment on the Prevention of Progression by Rosiglitazone on Atherosclerosis in diabetes patients with Cardiovascular History (APPROACH): Study design and baseline characteristics  Journal Articles
• Association Between Incretin-Based Drugs and the Risk of Acute Pancreatitis  Journal Articles
• Association of Metformin with Breast Cancer Incidence and Mortality in Patients with Type II Diabetes: A GRADE-Assessed Systematic Review and Meta-analysis  Journal Articles
• Associations of obesity with antidiabetic medication use after living kidney donation: An analysis of linked national registry and pharmacy fill records  Journal Articles
• Availability and affordability of essential medicines for diabetes across high-income, middle-income, and low-income countries: a prospective epidemiological study  Journal Articles
• Bacteria transmit metformin-associated lifespan extension  Journal Articles
• Basal Insulin and Cardiovascular and Other Outcomes  Journal Articles
• Basal Insulin and Cardiovascular and Other Outcomes in Dysglycemia  Journal Articles
• Basal insulin and cardiovascular and other outcomes.  Journal Articles
• Basal insulin glargine and microvascular outcomes in dysglycaemic individuals: results of the Outcome Reduction with an Initial Glargine Intervention (ORIGIN) trial  Journal Articles
• Biomarker Changes Associated With Both Dulaglutide and Cardiovascular Events in the REWIND Randomized Controlled Trial: A Nested Case-Control Post Hoc Analysis  Journal Articles
• Biomarkers of browning of white adipose tissue and their regulation during exercise- and diet-induced weight loss,  Journal Articles
• Blood pressure and mortality in patients with type 2 diabetes and a recent coronary event in the ELIXA trial  Journal Articles
• CONCEPTT: Continuous Glucose Monitoring in Women with Type 1 Diabetes in Pregnancy Trial: A multi-center, multi-national, randomized controlled trial - Study protocol  Journal Articles
• CVOT Summit 2022 Report: new cardiovascular, kidney, and glycemic outcomes  Journal Articles
• Call for effective therapies for preventing dementia in people with type 2 diabetes  Journal Articles
• Can PPARγ agonists have a role in the management of obesity-related hypertension?  Journal Articles
• Can community retail pharmacist and diabetes expert support facilitate insulin initiation by family physicians? Results of the AIM@GP randomized controlled trial  Journal Articles
• Can family physicians help patients initiate basal insulin therapy successfully?: randomized trial of patient-titrated insulin glargine compared with standard oral therapy: lessons for family practice from the Canadian INSIGHT trial.  Journal Articles
• CardioDiabetes: Core Competencies for Cardiovascular Clinicians in a Rapidly Evolving Era of Type 2 Diabetes Management  Journal Articles
• Cardiometabolic effects of rosiglitazone in patients with type 2 diabetes and coronary artery bypass grafts: A randomized placebo-controlled clinical trial  Journal Articles
• Cardiovascular Outcomes Trials in Type 2 Diabetes: Where Do We Go From Here? Reflections From aDiabetes CareEditors’ Expert Forum  Journal Articles
• Cardiovascular Outcomes Trials of Glucose-Lowering Drugs or Strategies in Type 2 Diabetes  Journal Articles
• Cardiovascular and Other Outcomes Postintervention With Insulin Glargine and Omega-3 Fatty Acids (ORIGINALE)  Journal Articles
• Cardiovascular and Renal Outcomes with Efpeglenatide in Type 2 Diabetes  Journal Articles
• Cardiovascular and metabolic effects of metformin in patients with type 1 diabetes (REMOVAL): a double-blind, randomised, placebo-controlled trial  Journal Articles
• Cardiovascular and mortality outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: A meta-analysis with the FREEDOM cardiovascular outcomes trial  Journal Articles
• Cardiovascular events and all‐cause mortality associated with sulphonylureas compared with other antihyperglycaemic drugs: A Bayesian meta‐analysis of survival data  Journal Articles
• Cardiovascular safety and glycemic control of glucagon-like peptide-1 receptor agonists for type 2 diabetes mellitus: A pairwise and network meta-analysis  Journal Articles
• Cardiovascular, Kidney, and Safety Outcomes With GLP-1 Receptor Agonists Alone and in Combination With SGLT2 Inhibitors in Type 2 Diabetes: A Systematic Review and Meta-Analysis.  Journal Articles
• Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials  Journal Articles
• Cellular Energy Sensing and Metabolism—Implications for Treating Diabetes: The 2017 Outstanding Scientific Achievement Award Lecture  Journal Articles
• Characteristics Associated With Maintenance of Mean A1C <6.5% in People With Dysglycemia in the ORIGIN Trial  Journal Articles
• Chronic Kidney Disease, Basal Insulin Glargine, and Health Outcomes in People with Dysglycemia: The ORIGIN Study  Journal Articles
• Clinical inertia in patients with T2DM requiring insulin in family practice.  Journal Articles
• Combined intensive blood pressure and glycemic control does not produce an additive benefit on microvascular outcomes in type 2 diabetic patients  Journal Articles
• Comment on Hempe et al. The Hemoglobin Glycation Index Identifies Subpopulations With Harms or Benefits From Intensive Treatment in the ACCORD Trial. Diabetes Care 2015;38:1067–1074  Journal Articles
• Comparative Effectiveness of Hypoglycemic Medications Among Veterans  Journal Articles
• Comparative effectiveness of SGLT2i versus GLP1-RA on cardiovascular outcomes in routine clinical practice  Journal Articles
• Comparative risk of new-onset diabetes following commencement of antipsychotics in New Zealand: a population-based clustered multiple baseline time series design  Journal Articles
• Comparing a daily versus weekly titration algorithm in people with type 2 diabetes switching from basal insulin to iGlarLixi in the LixiLan ONE CAN randomized trial  Journal Articles
• Comparison of medical resources and costs among patients with coronary heart disease and impaired glucose tolerance in the Acarbose Cardiovascular Evaluation trial  Journal Articles
• Condition‐related predictors of successful transition from paediatric to adult care among adolescents with Type 1 diabetes  Journal Articles
• Consensus Report: Definition and Interpretation of Remission in Type 2 Diabetes  Journal Articles
• Consensus report: Definition and interpretation of remission in type 2 diabetes  Journal Articles
• Consensus report: definition and interpretation of remission in type 2 diabetes  Journal Articles
• Considerations when prescribing trimethoprim-sulfamethoxazole  Journal Articles
• Cost implications of the use of basal insulin glargine in people with early dysglycemia: The ORIGIN trial  Journal Articles
• Cost-Effectiveness Analysis of a Randomized Trial Comparing Care Models for Chronic Kidney Disease  Journal Articles
• Cost-Utility Analysis of Low-Dose Pioglitazone in a Population With Prediabetes and a History of Stroke or Transient Ischemic Attack.  Journal Articles
• Crocetin Prevents Dexamethasone-Induced Insulin Resistance in Rats  Journal Articles
• Deprescribing antihyperglycemic agents in older persons: Evidence-based clinical practice guideline.  Journal Articles
• Design and baseline characteristics of participants in the Researching cardiovascular Events with a Weekly INcretin in Diabetes (REWIND) trial on the cardiovascular effects of dulaglutide  Journal Articles
• Design and baseline characteristics of the AMPLITUDE‐O cardiovascular outcomes trial of efpeglenatide, a weekly glucagon‐like peptide‐1 receptor agonist  Journal Articles
• Design of FLAT-SUGAR: Randomized Trial of Prandial Insulin Versus Prandial GLP-1 Receptor Agonist Together With Basal Insulin and Metformin for High-Risk Type 2 Diabetes  Journal Articles
• Design, history and results of the Thiazolidinedione Intervention with vitamin D Evaluation (TIDE) randomised controlled trial  Journal Articles
• Determinants of serious health outcome‐free status in middle‐aged and older people with dysglycaemia: Exploratory analysis of the ORIGIN trial  Journal Articles
• Determinants of sustained stabilization of beta-cell function following short-term insulin therapy in type 2 diabetes  Journal Articles
• Diabetes Mellitus in Living Pancreas Donors  Journal Articles
• Diabetes clinical trials: helped or hindered by the current shift in regulatory requirements?  Journal Articles
• Diabetes for Cardiologists: Practical Issues in Diagnosis and Management  Journal Articles
• Diabetes remission and relapse following an intensive metabolic intervention combining insulin glargine/lixisenatide, metformin and lifestyle approaches: Results of a randomised controlled trial  Journal Articles
• Diabetes, left ventricular systolic dysfunction, and chronic heart failure  Journal Articles
• Diagnosis, prognosis, and treatment of impaired glucose tolerance and impaired fasting glucose.  Journal Articles
• Dipeptidyl peptidase-4 inhibitors and risk of heart failure in type 2 diabetes: systematic review and meta-analysis of randomised and observational studies  Journal Articles
• Dipeptidyl peptidase‐4 inhibitor and insulin combination treatment in type 2 diabetes and chronic kidney disease: A meta‐analysis  Journal Articles
• Do sulphonylureas still have a place in clinical practice?  Journal Articles
• Do-It-Yourself Automated Insulin Delivery: A Position Statement  Journal Articles
• Does a Patient-Managed Insulin Intensification Strategy With Insulin Glargine and Insulin Glulisine Provide Similar Glycemic Control as a Physician-Managed Strategy? Results of the START (Self-Titration With Apidra to Reach Target) Study  Journal Articles
• Does hypoglycaemia increase the risk of cardiovascular events? A report from the ORIGIN trial  Journal Articles
• Does pioglitazone prevent macrovascular events in patients with type 2 diabetes?  Journal Articles
• Drugs in diabetes in 2016, changes in endocrinology in 2015. Dr. Hertzel Gerstein in an interview with Dr. Roman Jaeschke  Journal Articles
• Dulaglutide and a Composite Outcome Reflecting Atherosclerosis in the REWIND Trial: A Post Hoc Analysis  Journal Articles
• Dulaglutide and cardiovascular and heart failure outcomes in patients with and without heart failure: a post‐hoc analysis from the REWIND randomized trial  Conferences
• Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial  Journal Articles
• Dulaglutide and incident atrial fibrillation or flutter in patients with type 2 diabetes: A post hoc analysis from the REWIND randomized trial  Journal Articles
• Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial  Journal Articles
• Durable change in glycaemic control following intensive management of type 2 diabetes in the ACCORD clinical trial  Journal Articles
• Dysglycaemia as a cause of cardiovascular outcomes  Journal Articles
• Dysglycemia and a History of Reproductive Risk Factors  Journal Articles
• Early Metformin in Gestational Diabetes  Conferences
• Effect of Basal Insulin Glargine on First and Recurrent Episodes of Heart Failure Hospitalization  Journal Articles
• Effect of Computer-Generated Tailored Feedback on Glycemic Control in People With Diabetes in the Community  Journal Articles
• Effect of GLP-1 receptor agonists on waist circumference among type 2 diabetes patients: a systematic review and network meta-analysis  Journal Articles
• Effect of Glucagon-like Peptide-1 Receptor Agonists on Lipid Profiles Among Type 2 Diabetes: A Systematic Review and Network Meta-analysis  Journal Articles
• Effect of Hypoglycemia on Brain Structure in People With Type 2 Diabetes: Epidemiological Analysis of the ACCORD-MIND MRI Trial  Journal Articles
• Effect of Insulin Glargine and n-3FA on Carotid Intima-Media Thickness in People With Dysglycemia at High Risk for Cardiovascular Events  Journal Articles
• Effect of JTT-501 on net hepatic glucose balance and peripheral glucose uptake in alloxan-induced diabetic dogs  Journal Articles
• Effect of Lowering the Glycemic Load With Canola Oil on Glycemic Control and Cardiovascular Risk Factors: A Randomized Controlled Trial  Journal Articles
• Effect of Metformin vs Placebo on and Metabolic Factors in NCIC CTG MA.32  Journal Articles
• Effect of Oral Insulin on Prevention of Diabetes in Relatives of Patients With Type 1 Diabetes  Journal Articles
• Effect of Perioperative Insulin Infusion on Surgical Morbidity and Mortality: Systematic Review and Meta-analysis of Randomized Trials  Conferences
• Effect of Ramipril and of Rosiglitazone on Carotid Intima-Media Thickness in People With Impaired Glucose Tolerance or Impaired Fasting Glucose  Journal Articles
• Effect of Rosiglitazone and Ramipril on β-Cell Function in People With Impaired Glucose Tolerance or Impaired Fasting Glucose  Journal Articles
• Effect of Rosiglitazone on Progression of Coronary Atherosclerosis in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease  Journal Articles
• Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes  Journal Articles
• Effect of Swallow Balloon Therapy with the Combination of Semaglutide Oral Formulation: a Randomised Double-Blind Single-Centre Study  Journal Articles
• Effect of basal insulin and omega 3 fatty acids on cognitive impairment in dysglycaemia: An exploratory analysis of the ORIGIN trial  Journal Articles
• Effect of combining rosiglitazone with either metformin or insulin on β-cell mass and function in an animal model of Type 2 diabetes characterized by reduced β-cell mass at birth  Journal Articles
• Effect of dulaglutide on cognitive impairment in type 2 diabetes: an exploratory analysis of the REWIND trial  Journal Articles
• Effect of fenugreek (Trigonella foenum-graecumL.) intake on glycemia: a meta-analysis of clinical trials  Journal Articles
• Effect of incretin-based therapies on cancers of digestive system among 101 595 patients with type 2 diabetes mellitus: a systematic review and network meta-analysis combining 84 trials with a median duration of 30 weeks  Journal Articles
• Effect of insulin on the inflammatory and acute phase response after burn injury  Journal Articles
• Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial  Journal Articles
• Effect of lixisenatide on natriuretic peptides in people with type 2 diabetes and recent acute coronary syndrome: The ELIXA trial  Journal Articles
• Effect of lorcaserin on prevention and remission of type 2 diabetes in overweight and obese patients (CAMELLIA-TIMI 61): a randomised, placebo-controlled trial  Journal Articles
• Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial  Journal Articles
• Effect of targeting normal fasting glucose levels with basal insulin glargine on glycaemic variability and risk of hypoglycaemia: a randomized, controlled study in patients with early Type 2 diabetes  Journal Articles
• Effect of thiazolidinediones and insulin on cognitive outcomes in ACCORD-MIND  Journal Articles
• Effectiveness of metformin to pregnant women with PCOS to reduce spontaneous abortion and gestational diabetes mellitus: a protocol for an overview of reviews  Journal Articles
• Effectiveness of pharmacological interventions for managing obesity in children and adolescents: A systematic review and meta-analysis framed using minimal important difference estimates based on GRADE guidance to inform a clinical practice guideline.  Journal Articles
• Effectiveness, safety, initial optimal dose, and optimal maintenance dose range of basal insulin regimens for type 2 diabetes: A systematic review with meta‐analysis  Journal Articles
• Effects and patient compliance of sustained‐release versus immediate‐release glipizides in patients with type 2 diabetes mellitus: a systematic review and meta‐analysis  Journal Articles
• Effects of Cardiac Autonomic Dysfunction on Mortality Risk in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial  Journal Articles
• Effects of Glucagon-Like Peptide-1 Receptor Agonists on Weight Loss in Patients with Type 2 Diabetes: A Systematic Review and Network Meta-Analysis  Journal Articles
• Effects of Incretin-based Therapies on Weight-related Indicators among Patients with Type 2 Diabetes: A Network Meta-analysis.  Journal Articles
• Effects of Intensive Glucose Lowering in Type 2 Diabetes  Journal Articles
• Effects of Medical Therapies on Retinopathy Progression in Type 2 Diabetes  Journal Articles
• Effects of Ramipril and Rosiglitazone on Cardiovascular and Renal Outcomes in People With Impaired Glucose Tolerance or Impaired Fasting Glucose  Journal Articles
• Effects of Randomization to Intensive Glucose Control on Adverse Events, Cardiovascular Disease, and Mortality in Older Versus Younger Adults in the ACCORD Trial  Journal Articles
• Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trial  Journal Articles
• Effects of basal insulin glargine and omega-3 fatty acid on cognitive decline and probable cognitive impairment in people with dysglycaemia: a substudy of the ORIGIN trial  Journal Articles
• Effects of ethnicity on diabetes incidence and prevention: results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial  Journal Articles
• Effects of glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors on cardiovascular and kidney outcomes in Asian versus White patients with type 2 diabetes mellitus  Journal Articles
• Effects of intensive glucose control on microvascular outcomes in patients with type 2 diabetes: a meta-analysis of individual participant data from randomised controlled trials  Journal Articles
• Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND): a randomised open-label substudy  Journal Articles
• Effects of intensive glycaemic control on ischaemic heart disease – Authors' reply  Journal Articles
• Effects of intensive glycaemic control on ischaemic heart disease: analysis of data from the randomised, controlled ACCORD trial  Journal Articles
• Effects of rosiglitazone on ovarian function and fertility in animals with reduced fertility following fetal and neonatal exposure to nicotine  Journal Articles
• Effects of the Once-Weekly Glucagon-Like Peptide-1 Receptor Agonist Dulaglutide on Ambulatory Blood Pressure and Heart Rate in Patients With Type 2 Diabetes Mellitus  Journal Articles
• Effects of the dual peroxisome proliferator–activated receptor activator aleglitazar in patients with Type 2 Diabetes mellitus or prediabetes  Journal Articles
• Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes  Journal Articles
• Efficacy and Safety of Dulaglutide in Older Patients: A post hoc Analysis of the REWIND trial  Journal Articles
• Efficacy and safety outcomes of dulaglutide by baseline HbA1c: A post hoc analysis of the REWIND trial  Journal Articles
• Efpeglenatide and Clinical Outcomes With and Without Concomitant Sodium-Glucose Cotransporter-2 Inhibition Use in Type 2 Diabetes: Exploratory Analysis of the AMPLITUDE-O Trial  Journal Articles
• Efpeglenatide and Heart and Kidney Outcomes in Type 2 Diabetes  Journal Articles
• Emergency interventions for hyperkalaemia  Journal Articles
• Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes mellitus. Dr. Hertzel Gerstein in an interview with Dr. Roman Jaeschke  Journal Articles
• Enhanced activation of cellular AMPK by dual-small molecule treatment: AICAR and A769662  Journal Articles
• Epigenetics, heritability and longitudinal analysis  Journal Articles
• Erectile function in men with type 2 diabetes treated with dulaglutide: an exploratory analysis of the REWIND placebo-controlled randomised trial  Journal Articles
• Evaluating remission of type 2 diabetes using a metabolic intervention including fixed-ratio insulin degludec and liraglutide: A randomized controlled trial.  Journal Articles
• Evaluating the evidence for macrophage presence in skeletal muscle and its relation to insulin resistance in obese mice and humans: a systematic review protocol  Journal Articles
• Evaluation of a chronic disease management system for the treatment and management of diabetes in primary health care practices in Ontario: an observational study.  Journal Articles
• Evaluation of in-stent restenosis in the APPROACH trial (assessment on the prevention of progression by Rosiglitazone on atherosclerosis in diabetes patients with cardiovascular history)  Journal Articles
• Evaluation of metformin in early breast cancer: a modification of the traditional paradigm for clinical testing of anti-cancer agents  Journal Articles
• Exercise intensity and insulin sensitivity: how low can you go?  Journal Articles
• Exploring potential mediators of the cardiovascular benefit of dulaglutide in type 2 diabetes patients in REWIND  Journal Articles
• Exploring the Relationship Between Efpeglenatide Dose and Cardiovascular Outcomes in Type 2 Diabetes: Insights From the AMPLITUDE-O Trial  Journal Articles
• Familial Permanent Neonatal Diabetes with KCNJ11 Mutation and the Response to Glyburide Therapy - A Three-Year Follow-Up  Journal Articles
• Fracture Risk of Sodium-Glucose Cotransporter-2 Inhibitors in Chronic Kidney Disease  Journal Articles
• GLP-1 receptor agonist versus DPP-4 inhibitor and kidney and cardiovascular outcomes in clinical practice in type-2 diabetes  Journal Articles
• GLP-1 receptor agonists for Parkinson's disease  Journal Articles
• GPs' approach to insulin prescribing in older patients: a qualitative study  Journal Articles
• Generalizability of glucagon‐like peptide‐1 receptor agonist cardiovascular outcome trials to the overall type 2 diabetes population in the United States  Journal Articles
• Generalizability of results from the recent FDA-guided cardiovascular outcomes trials to a representative population with Type 2 Diabetes attending primary care clinics  Journal Articles
• Genetic Predictors of Cardiovascular Mortality During Intensive Glycemic Control in Type 2 Diabetes: Findings From the ACCORD Clinical Trial  Journal Articles
• Glucagon-like peptide-1 receptor agonists and heart failure in type 2 diabetes: systematic review and meta-analysis of randomized and observational studies  Journal Articles
• Glucose: a Continuous Risk Factor for Cardiovascular Disease  Journal Articles
• Glucosensing in an immortalized adrenomedullary chromaffin cell line: Role of ATP-sensitive K+ channels  Journal Articles
• Glycemia Treatment Strategies in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial  Journal Articles
• Glycemic control in the ICU: a multicenter survey  Journal Articles
• Growth Differentiation Factor 15 as a Novel Biomarker for Metformin  Journal Articles
• Guidelines for the use of an insulin infusion for the management of hyperglycemia in critically ill patients  Journal Articles
• HbA1c Change and Diabetic Retinopathy During GLP-1 Receptor Agonist Cardiovascular Outcome Trials: A Meta-analysis and Meta-regression  Journal Articles
• HbA1c Reduction in Dulaglutide-Treated Patients Irrespective of Duration of Diabetes, Microvascular Disease, and BMI: A Post Hoc Analysis From the REWIND Trial  Journal Articles
• Health-related quality of life deficits associated with varying degrees of disease severity in type 2 diabetes.  Journal Articles
• Heart failure and mortality outcomes in patients with type 2 diabetes taking alogliptin versus placebo in EXAMINE: a multicentre, randomised, double-blind trial  Journal Articles
• Heart failure: a cardiovascular outcome in diabetes that can no longer be ignored  Journal Articles
• Hormonal Regulation of Cystathionine β-Synthase Expression in Liver  Journal Articles
• Hospitalization costs with degludec versus glargine U100 for patients with type 2 diabetes at high cardiovascular risk: Canadian costs applied to SAEs from a randomized outcomes trial  Journal Articles
• Hyperglycemia Has a Stronger Relation with Outcome in Trauma Patients than in Other Critically Ill Patients  Journal Articles
• Hyperinsulinemia Precedes Insulin Resistance in Mice Lacking Pancreatic β-Cell Leptin Signaling  Journal Articles
• Hypoglycemia Incidence in Older Adults by Estimated GFR  Journal Articles
• Hypoglycemia and Incident Cognitive Dysfunction: A Post Hoc Analysis From the ORIGIN Trial  Journal Articles
• Hypoglycemia and Risk of Death in Critically Ill Patients  Journal Articles
• Hypoglycemia in Adults  Journal Articles
• Hypoglycemia: The Dangerous Side of Great Control  Journal Articles
• Hypoglycemic hemiparesis as stroke mimic with transient splenial lesion and internal capsule involvement: A reversible clinico-radiological concurrence  Journal Articles
• INSULIN ATTENUATES THE CYTOKINE RESPONSE IN A BURN WOUND INFECTION MODEL  Journal Articles
• Impact of GLP-1 Receptor Agonists on Major Gastrointestinal Disorders for Type 2 Diabetes Mellitus: A Mixed Treatment Comparison Meta-Analysis  Journal Articles
• Impact of GLP-1 receptor agonists on blood pressure, heart rate and hypertension among patients with type 2 diabetes: A systematic review and network meta-analysis  Journal Articles
• Impact of Regulatory Guidance on Evaluating Cardiovascular Risk of New Glucose-Lowering Therapies to Treat Type 2 Diabetes Mellitus  Journal Articles
• Impact of baseline FIB-4 score on efpeglenatide benefits on cardiovascular outcomes in people with type 2 diabetes: a participant-level exploratory analysis of the AMPLITUDE-O trial.  Journal Articles
• Impact of previous gestational diabetes management on perinatal outcomes in subsequent pregnancies affected by gestational diabetes mellitus  Journal Articles
• Impact of the COVID-19 Pandemic on Antihyperglycemic Prescriptions for Adults With Type 2 Diabetes in Canada: A Cross-sectional Study  Journal Articles
• Impaired endothelial antithrombotic activity following short-term interruption of continuous subcutaneous insulin infusion in type1 diabetic patients  Journal Articles
• Impaired renal function modifies the risk of severe hypoglycaemia among users of insulin but not glyburide: a population-based nested case–control study  Journal Articles
• In high-risk T1DM, real-time continuous glucose monitoring vs self-monitoring reduced hypoglycemic events  Journal Articles
• In reply: Regarding the survey on perioperative diabetes medications and glucose control  Journal Articles
• In vitro and in vivo antidiabetic activity of isolated fraction of Prosopis cineraria against streptozotocin-induced experimental diabetes: A mechanistic study  Journal Articles
• Incidence of Diabetes Following Ramipril or Rosiglitazone Withdrawal  Journal Articles
• Increased skeletal muscle glucose uptake by rosemary extract through AMPK activation  Journal Articles
• Increases in Natriuretic Peptides Precede Heart Failure Hospitalization in Patients With a Recent Coronary Event and Type 2 Diabetes Mellitus  Journal Articles
• Incretin based drugs and the risk of pancreatic cancer: international multicentre cohort study  Journal Articles
• Incretin based treatments and mortality in patients with type 2 diabetes: systematic review and meta-analysis  Journal Articles
• Incretin treatment and risk of pancreatitis in patients with type 2 diabetes mellitus: systematic review and meta-analysis of randomised and non-randomised studies  Journal Articles
• Inpatient Glycemic Control  Journal Articles
• Insulin Attenuates Apoptosis and Exerts Anti-Inflammatory Effects in Endotoxemic Human Macrophages  Journal Articles
• Insulin Attenuates the Systemic Inflammatory Response in Endotoxemic Rats  Journal Articles
• Insulin Attenuates the Systemic Inflammatory Response to Thermal Trauma  Journal Articles
• Insulin Decreases Inflammatory Signal Transcription Factor Expression in Primary Human Liver Cells after LPS Challenge  Journal Articles
• Insulin Resistance Postburn: Underlying Mechanisms and Current Therapeutic Strategies  Journal Articles
• Insulin Treatment Improves the Systemic Inflammatory Reaction to Severe Trauma  Journal Articles
• Insulin and muscle protein turnover in humans: stimulatory, permissive, inhibitory, or all of the above?  Journal Articles
• Insulin prevents liver damage and preserves liver function in lipopolysaccharide-induced endotoxemic rats  Journal Articles
• Insulin resistance and cardiovascular outcomes in the ORIGIN trial  Journal Articles
• Insulin therapy in acute coronary syndromes: an appraisal of completed and ongoing randomised trials with important clinical end points  Journal Articles
• Insulin treatment and clinical outcomes in patients with diabetes and heart failure with preserved ejection fraction  Journal Articles
• Insulin use for type 2 diabetes: the challenges of predicting trends and modelling care  Journal Articles
• Insulin-sparing effect of hydroxychloroquine in diabetic rats is concentration dependent  Journal Articles
• Intensive Insulin Therapy in Severely Burned Pediatric Patients  Journal Articles
• Intensive insulin treatment increases donor site wound protein synthesis in burn patients  Journal Articles
• Intensive versus Conventional Glucose Control in Critically Ill Patients  Journal Articles
• Intensivierte Insulintherapie bei Sepsis-Verbesserung der �berlebenschancen?  Journal Articles
• International Diabetes Federation document concerning postmeal glycemic control: assessment of quality of clinical practice guidelines using AGREE instrument  Journal Articles
• Intravenous Vitamin C in Adults with Sepsis in the Intensive Care Unit  Journal Articles
• Involvement of the actin network in insulin signalling.  Conferences
• Is it Time to Test Metformin in Breast Cancer Prevention Trials? a Reply to the Authors  Journal Articles
• Is it possible to reduce cardiovascular risk with glucose-lowering approaches?  Journal Articles
• Is newly diagnosed type 2 diabetes treated according to the guidelines? Results of the Polish ARETAEUS1 study.  Journal Articles
• Is regression to normoglycaemia clinically important?  Journal Articles
• Lack of Association Between Thiazolidinediones and Macular Edema in Type 2 Diabetes  Journal Articles
• Letter by Wong and Demers Regarding Article, “Efficacy and Safety of Dapagliflozin According to Frailty in Patients With Heart Failure: A Prespecified Analysis of the DELIVER Trial”  Journal Articles
• Lifestyle, Glycosylated Hemoglobin A1c, and Survival Among Patients With Stable Ischemic Heart Disease and Diabetes  Journal Articles
• Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome  Journal Articles
• Long-Term Effects of Intensive Glucose Lowering on Cardiovascular Outcomes  Journal Articles
• Long-term effect of rosiglitazone and/or ramipril on the incidence of diabetes  Journal Articles
• Low-dose combination therapy with rosiglitazone and metformin to prevent type 2 diabetes mellitus (CANOE trial): a double-blind randomised controlled study  Journal Articles
• Low-glycaemic index diet to improve glycaemic control and cardiovascular disease in type 2 diabetes: design and methods for a randomised, controlled, clinical trial  Journal Articles
• Lowering of Glucose in Critical care: a randomized pilot trial  Journal Articles
• Lowering of hemoglobin A1C and risk of cardiovascular outcomes and all-cause mortality, a meta-regression analysis  Journal Articles
• Management of Hyperglycemia in Hospitalized Adult Patients in Non-Critical Care Settings: An Endocrine Society Clinical Practice Guideline  Journal Articles
• Management of Individuals With Diabetes at High Risk for Hypoglycemia: An Endocrine Society Clinical Practice Guideline  Journal Articles
• Management of mitochondrial diabetes in the era of novel therapies  Journal Articles
• Management of type 2 diabetes using non‐insulin glucose‐lowering therapies: a critical appraisal of clinical practice guidelines with the AGREE II instrument  Journal Articles
• Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy: A Consensus Statement of the American Diabetes Association and the European Association for the Study of Diabetes  Journal Articles
• Metformin adapts its cellular effects to bioenergetic status in a model of metabolic dysfunction  Journal Articles
• Metformin alleviates muscle wasting post-thermal injury by increasing Pax7-positive muscle progenitor cells  Journal Articles
• Metformin and salicylate synergistically activate liver AMPK, inhibit lipogenesis and improve insulin sensitivity  Journal Articles
• Metformin for the management of peri‐operative hyperglycaemia  Journal Articles
• Metformin in adults with type 1 diabetes: Design and methods of REducing with MetfOrmin Vascular Adverse Lesions (REMOVAL): An international multicentre trial  Journal Articles
• Metformin in women with type 2 diabetes in pregnancy (MiTy): a multicentre, international, randomised, placebo-controlled trial  Journal Articles
• Metformin increases peroxisome proliferator-activated receptor γ Co-activator-1α and utrophin a expression in dystrophic skeletal muscle  Journal Articles
• Metformin or Oral Contraceptives for Adolescents With Polycystic Ovarian Syndrome: A Meta-analysis  Journal Articles
• Metformin, diet and breast cancer: An avenue for chemoprevention  Journal Articles
• Metformin-induced increases in GDF15 are important for suppressing appetite and promoting weight loss  Journal Articles
• Metformin-induced metabolic reprogramming of chemoresistant ALDHbright breast cancer cells  Journal Articles
• Modulation of GLP-1 Levels by a Genetic Variant That Regulates the Cardiovascular Effects of Intensive Glycemic Control in ACCORD  Journal Articles
• Monitoring Vitamin B12 in Women Treated with Metformin for Primary Prevention of Breast Cancer and Age-Related Chronic Diseases  Journal Articles
• Multicenter randomized trial of a comprehensive prepared meal program in type 2 diabetes.  Journal Articles
• New-onset hyperglycemia immediately after liver transplantation: A national survey from China Liver Transplant Registry  Journal Articles
• Newly prescribed canagliflozin vs. GLP-1 agonists was linked to amputation in older adults with type 2 DM and CVD  Journal Articles
• Nine-Year Effects of 3.7 Years of Intensive Glycemic Control on Cardiovascular Outcomes  Journal Articles
• Novel Indices of Cognitive Impairment and Incident Cardiovascular Outcomes in the REWIND Trial  Journal Articles
• Nuclear SIRT1 activity, but not protein content, regulates mitochondrial biogenesis in rat and human skeletal muscle  Journal Articles
• Oligomeric resistin impairs insulin and AICAR-stimulated glucose uptake in mouse skeletal muscle by inhibiting GLUT4 translocation  Journal Articles
• Oral Pharmacologic Treatment of Type 2 Diabetes Mellitus: A Clinical Practice Guideline Update From the American College of Physicians  Journal Articles
• Oral antidiabetic drugs: bioavailability assessment of fixed-dose combination tablets of pioglitazone and metformin. Effect of body weight, gender, and race on systemic exposures of each drug.  Journal Articles
• Oral antidiabetic drugs: effect of food on absorption of pioglitazone and metformin from a fixed-dose combination tablet.  Journal Articles
• Patient Age, Ethnicity, Medical History, and Risk Factor Profile, but Not Drug Insurance Coverage, Predict Successful Attainment of Glycemic Targets  Journal Articles
• Patient-important outcomes in diabetes—time for consensus  Journal Articles
• Pharmacologic Glycemic Management of Type 2 Diabetes in Adults: 2020 Update – The User’s Guide  Journal Articles
• Pharmacologic Management of Type 2 Diabetes  Journal Articles
• Pharmacologic Management of Type 2 Diabetes: 2016 Interim Update  Journal Articles
• Piloting a Novel Algorithm for Glucose Control in the Coronary Care Unit  Journal Articles
• Piloting a Remission Strategy in Type 2 Diabetes: Results of a Randomized Controlled Trial  Journal Articles
• Pioglitazone increases VEGFR3 expression and promotes activation of M2 macrophages via the peroxisome proliferator‑activated receptor γ  Journal Articles
• Policies, Guidelines and Consensus Statements: Pharmacologic Management of Type 2 Diabetes–2015 Interim Update  Journal Articles
• Poor achievement of guidelines-recommended targets in type 2 diabetes: findings from a contemporary prospective cohort study  Journal Articles
• Predictive models for cardiovascular and kidney outcomes in patients with type 2 diabetes: systematic review and meta-analyses  Journal Articles
• Predictors of Nonsevere and Severe Hypoglycemia During Glucose-Lowering Treatment With Insulin Glargine or Standard Drugs in the ORIGIN Trial  Journal Articles
• Preventing type 2 diabetes using combination therapy: design and methods of the CAnadian Normoglycaemia Outcomes Evaluation (CANOE) trial  Journal Articles
• Pre‐prandial vs. post‐prandial capillary glucose measurements as targets for repaglinide dose titration in people with diet‐treated or metformin‐treated Type 2 diabetes: a randomized controlled clinical trial  Journal Articles
• Progression through diabetes therapies among new elderly users of metformin: a population‐based study  Journal Articles
• RCPE UK Consensus Statement on Diabetes  Conferences
• Randomized trial of insulin versus usual care in reducing restenosis after coronary intervention in patients with diabetes. the STent Restenosis And Metabolism (STREAM) study  Journal Articles
• Rationale for and design of the Acarbose Cardiovascular Evaluation (ACE) trial  Journal Articles
• Rationale, design and baseline characteristics of the effect of ticagrelor on health outcomes in diabetes mellitus patients Intervention study  Journal Articles
• Rationale, design and recruitment characteristics of a large, simple international trial of diabetes prevention: the DREAM trial  Journal Articles
• Rationale, design, and baseline characteristics for a large international trial of cardiovascular disease prevention in people with dysglycemia: The ORIGIN Trial (Outcome Reduction with an Initial Glargine Intervention)  Journal Articles
• Reducing the Risk of Developing Diabetes  Journal Articles
• Reducing the Risk of Developing Diabetes  Journal Articles
• Reduction in heart failure outcomes with SGLT2 inhibitors irrespective of glycaemic status  Journal Articles
• Regulation of the water channel aquaporin‐1: isolation and reconstitution of the regulatory complex  Journal Articles
• Relation between HbA1c and incident cardiovascular disease over a period of 6 years in the Hong Kong population  Journal Articles
• Relationship Between A1C and Fasting Plasma Glucose in Dysglycemia or Type 2 Diabetes  Journal Articles
• Relationship between Escherichia coli O157:H7 and diabetes mellitus  Conferences
• Remission of Type 2 Diabetes Following a Short-term Intensive Intervention With Insulin Glargine, Sitagliptin, and Metformin: Results of an Open-label Randomized Parallel-Design Trial  Journal Articles
• Remission of Type 2 Diabetes Following a Short-term Intervention With Insulin Glargine, Metformin, and Dapagliflozin  Journal Articles
• Reply to Du et al.—Obvious Differences Between GLP1RAs and SGLT2is in the Outcomes of Heart Failure, Renal Failure, and Stroke  Journal Articles
• Response to Comment on: The ORIGIN Trial Investigators. Characteristics Associated With Maintenance of Mean A1C <6.5% in People With Dysglycemia in the ORIGIN Trial. Diabetes Care 2013;36:2915–2922  Journal Articles
• Response to Suissa and Azoulay. The Association of Basal Insulin Glargine and/or n-3 Fatty Acids With Incident Cancers in Patients With Dysglycemia. Diabetes Care 2014;37:1360–1366  Journal Articles
• Response to Zanders et al. The Association of Basal Insulin Glargine and/or n-3 Fatty Acids With Incident Cancers in Patients With Dysglycemia. Diabetes Care 2014;37:1360–1366  Journal Articles
• Risk Factor Control for Coronary Artery Disease Secondary Prevention in Large Randomized Trials  Journal Articles
• Rosiglitazone improves pancreatic mitochondrial function in an animal model of dysglycemia: role of the insulin-like growth factor axis  Journal Articles
• Rosiglitazone prevents diabetes by increasing beta‐cell mass in an animal model of type 2 diabetes characterized by reduced beta‐cell mass at birth  Journal Articles
• Safety and efficacy of dipeptidyl peptidase-4 inhibitors vs sulfonylurea in metformin-based combination therapy for type 2 diabetes mellitus: Systematic review and meta-analysis  Journal Articles
• Safety, effectiveness, and cost effectiveness of long acting versus intermediate acting insulin for patients with type 1 diabetes: systematic review and network meta-analysis  Journal Articles
• Salicylate activates AMPK and synergizes with metformin to reduce the survival of prostate and lung cancer cells ex vivo through inhibition of de novo lipogenesis  Journal Articles
• Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus  Journal Articles
• Secular trends in antihyperglycaemic medication prescriptions in older adults with diabetes and chronic kidney disease: 2004–2013  Journal Articles
• Serious Cardiovascular Outcomes in Diabetes  Journal Articles
• Short‐term intensive insulin as induction and maintenance therapy for the preservation of beta‐cell function in early type 2 diabetes (RESET‐IT Main): A 2‐year randomized controlled trial  Journal Articles
• Similar cardiovascular outcomes in patients with diabetes and established or high risk for coronary vascular disease treated with dulaglutide with and without baseline metformin  Journal Articles
• Sliding scale insulin for non-critically ill hospitalised adults with diabetes mellitus  Journal Articles
• Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials  Journal Articles
• Sodium-glucose cotransporter-2 (SGLT-2) inhibitors for adults with chronic kidney disease: a clinical practice guideline.  Journal Articles
• Sodium–glucose cotransporter-2 inhibitors in patients without diabetes  Journal Articles
• Strategies to detect abnormal glucose metabolism in people at high risk of cardiovascular disease from the ORIGIN (Outcome Reduction with Initial Glargine Intervention) trial population  Journal Articles
• Surgical and Advanced Medical Therapy for the Treatment of Type 2 Diabetes in Class I Obese Patients: a Short-Term Outcome  Journal Articles
• THE ROLE OF HYPERGLYCEMIA IN BURNED PATIENTS  Journal Articles
• Targets for Glycemic Control  Journal Articles
• Testosterone and sex hormone-binding globulin in dysglycemic women at high cardiovascular risk: A report from the Outcome Reduction with an Initial Glargine Intervention trial  Journal Articles
• Testosterone, sex hormone-binding globulin and risk of cardiovascular events: A report from the Outcome Reduction with an Initial Glargine Intervention trial  Journal Articles
• The Association of Basal Insulin Glargine and/or n-3 Fatty Acids With Incident Cancers in Patients With Dysglycemia  Journal Articles
• The Diabetes Mellitus Medication Choice Decision Aid  Journal Articles
• The Economic Value of a New Insulin Preparation, Humalog?? Mix 25???  Journal Articles
• The Effect of Metformin on Mortality Following Cancer among Patients with Diabetes  Journal Articles
• The Effect of Oral Antidiabetic Agents on A1C Levels  Journal Articles
• The Effectiveness of Sodium-Glucose Cotransporter 2 Inhibitors and Glucagon-like Peptide-1 Receptor Agonists on Cardiorenal Outcomes: Systematic Review and Meta-analysis  Journal Articles
• The Hypoglycemic Risk of Glyburide (Glibenclamide) Compared with Modified-Release Gliclazide  Journal Articles
• The JDRF CCTN CGM TIME Trial: Timing of Initiation of continuous glucose Monitoring in Established pediatric type 1 diabetes: study protocol, recruitment and baseline characteristics  Journal Articles
• The Suppressor of Cytokine Signaling 3 Inhibits Leptin Activation of AMP-Kinase in Cultured Skeletal Muscle of Obese Humans  Journal Articles
• The cardiovascular effect of incretin-based therapies among type 2 diabetes: a systematic review and network meta-analysis  Journal Articles
• The cardiovascular effects of glucagon-like peptide-1 receptor agonists: a trial sequential analysis of randomized controlled trials  Journal Articles
• The effect of adding metformin to insulin therapy for type 1 diabetes mellitus children: A systematic review and meta-analysis  Journal Articles
• The effect of basal insulin glargine on the fibrinolytic system and von Willebrand factor in people with dysglycaemia and high risk for cardiovascular events: Swedish substudy of the Outcome Reduction with an Initial Glargine Intervention trial  Journal Articles
• The effect of dulaglutide on stroke: an exploratory analysis of the REWIND trial  Journal Articles
• The effectiveness and safety of treatments used for polycystic ovarian syndrome management in adolescents: a systematic review and network meta-analysis protocol  Journal Articles
• The effectiveness of hydroxychloroquine in patients with type 2 diabetes mellitus who are refractory to sulfonylureas—a randomized trial  Journal Articles
• The effectiveness of sodium-glucose co-transporter 2 inhibitors on cardiorenal outcomes: an updated systematic review and meta-analysis  Journal Articles
• The effects of baseline characteristics, glycaemia treatment approach, and glycated haemoglobin concentration on the risk of severe hypoglycaemia: post hoc epidemiological analysis of the ACCORD study  Journal Articles
• The effects of metformin on endogenous androgens and SHBG in women: a systematic review and meta-analysis  Journal Articles
• The efficacy and safety of glucose control algorithms in intensive care: a pilot study of the Survival Using Glucose Algorithm Regulation (SUGAR) trial  Journal Articles
• The impact of bariatric surgery on insulin-treated type 2 diabetes patients  Journal Articles
• The impact of oral hypoglycemics and statins on outcomes in myelodysplastic syndromes  Journal Articles
• The use of exenatide in severely burned pediatric patients  Journal Articles
• Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial  Journal Articles
• Tight Glycemic Control, Inflammation, and the ICU: Evidence for Heterogeneous Treatment Effects in Two Randomized Controlled Trials  Journal Articles
• Total cardiovascular or fatal events in people with type 2 diabetes and cardiovascular risk factors treated with dulaglutide in the REWIND trail: a post hoc analysis  Journal Articles
• Treatment satisfaction and quality of life using an early insulinization strategy with insulin glargine compared to an adjusted oral therapy in the management of Type 2 diabetes: The Canadian INSIGHT Study  Journal Articles
• Trends in Antihyperglycemic Medication Prescriptions and Hypoglycemia in Older Adults: 2002-2013  Journal Articles
• Trends in selection and timing of first‐line pharmacotherapy in older patients with Type 2 diabetes diagnosed between 1994 and 2006  Journal Articles
• Troglitazone monotherapy improves glycemic control in patients with type 2 diabetes mellitus: a randomized, controlled study. The Troglitazone Study Group.  Journal Articles
• Type 2 diabetes patients’ and providers’ differing perspectives on medication nonadherence: a qualitative meta-synthesis  Journal Articles
• Ultrasound Stimulation of Insulin Release from Pancreatic Beta Cells as a Potential Novel Treatment for Type 2 Diabetes  Journal Articles
• Update and Next Steps for Real-World Translation of Interventions for Type 2 Diabetes Prevention: Reflections From a Diabetes Care Editors’ Expert Forum  Journal Articles
• Use of Classes of Antihyperglycemic Agents in People With Type 2 Diabetes Based on Level of Estimated Glomerular Filtration Rate  Journal Articles
• Use of sodium–glucose cotransporter-2 inhibitors and risk of acute kidney injury in older adults with diabetes: a population-based cohort study  Journal Articles
• Validation of the classification for type 2 diabetes into five subgroups: a report from the ORIGIN trial  Conferences
• Values, preferences and burden of treatment for the initiation of GLP-1 receptor agonists and SGLT-2 inhibitors in adult patients with type 2 diabetes: a systematic review  Journal Articles
• Variation at the NFATC2 Locus Increases the Risk of Thiazolidinedione-Induced Edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) Study  Journal Articles
• Waking up from the DREAM of preventing diabetes with drugs  Journal Articles
• What, How, and How Much Should Patients with Burns be Fed?  Journal Articles
• Worth Their Weight? An Update on New and Emerging Pharmacologic Agents for Obesity and Their Potential Role for Persons with Cardiac Conditions  Journal Articles
• n–3 Fatty Acids and Cardiovascular Outcomes in Dysglycemia  Journal Articles
• n–3 Fatty Acids and Cardiovascular Outcomes in Patients with Dysglycemia  Journal Articles